Cargando…
No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438218/ https://www.ncbi.nlm.nih.gov/pubmed/19954267 http://dx.doi.org/10.18553/jmcp.2009.15.9.759 |
_version_ | 1785092741024186368 |
---|---|
author | Curtiss, Frederic R. |
author_facet | Curtiss, Frederic R. |
author_sort | Curtiss, Frederic R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10438218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104382182023-08-21 No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents Curtiss, Frederic R. J Manag Care Pharm Editorials Academy of Managed Care Pharmacy 2009-11 /pmc/articles/PMC10438218/ /pubmed/19954267 http://dx.doi.org/10.18553/jmcp.2009.15.9.759 Text en Copyright © 2009, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Editorials Curtiss, Frederic R. No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title | No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title_full | No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title_fullStr | No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title_full_unstemmed | No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title_short | No TREATment with Darbepoetin Dosed to Hemoglobin 13 Grams per Deciliter in Type 2 Diabetes with Pre-Dialysis Chronic Kidney Disease - Safety Warnings for Erythropoiesis-Stimulating Agents |
title_sort | no treatment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease - safety warnings for erythropoiesis-stimulating agents |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438218/ https://www.ncbi.nlm.nih.gov/pubmed/19954267 http://dx.doi.org/10.18553/jmcp.2009.15.9.759 |
work_keys_str_mv | AT curtissfredericr notreatmentwithdarbepoetindosedtohemoglobin13gramsperdeciliterintype2diabeteswithpredialysischronickidneydiseasesafetywarningsforerythropoiesisstimulatingagents |